The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Orally Disintegrating Tablets Market Research Report 2025
Synopsis
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
The global Orally Disintegrating Tablets market was valued at US$ 13890 million in 2023 and is anticipated to reach US$ 30610 million by 2030, witnessing a CAGR of 11.7% during the forecast period 2024-2030.
Global Orally Disintegrating Tablet main manufactuers include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb and Conquer, totally accounting for about 17% of the market. North America is the largest market of glass packaging, holding a share more than 40%. As for the types of products, it can be divided into anti-psychotics drug, anti-epileptics drug and others. As for the applications of products, it is widely used in CNS diseases, gastrointestinal diseases, CVS diseases and others. The most common application is in CNS diseases packaging, with a share about 55%.
This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Tablets.
Report Scope
The Orally Disintegrating Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Orally Disintegrating Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orally Disintegrating Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
Segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Segment by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Orally Disintegrating Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Orally Disintegrating Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
The global Orally Disintegrating Tablets market was valued at US$ 13890 million in 2023 and is anticipated to reach US$ 30610 million by 2030, witnessing a CAGR of 11.7% during the forecast period 2024-2030.
Global Orally Disintegrating Tablet main manufactuers include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb and Conquer, totally accounting for about 17% of the market. North America is the largest market of glass packaging, holding a share more than 40%. As for the types of products, it can be divided into anti-psychotics drug, anti-epileptics drug and others. As for the applications of products, it is widely used in CNS diseases, gastrointestinal diseases, CVS diseases and others. The most common application is in CNS diseases packaging, with a share about 55%.
This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Tablets.
Report Scope
The Orally Disintegrating Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Orally Disintegrating Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orally Disintegrating Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
Segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Segment by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Orally Disintegrating Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Orally Disintegrating Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Orally Disintegrating Tablets Market Overview
1.1 Product Overview and Scope of Orally Disintegrating Tablets
1.2 Orally Disintegrating Tablets Segment by Type
1.2.1 Global Orally Disintegrating Tablets Market Value Comparison by Type (2024-2030)
1.2.2 Anti-Psychotics Drug
1.2.3 Anti-Epileptics Drug
1.2.4 Other
1.3 Orally Disintegrating Tablets Segment by Application
1.3.1 Global Orally Disintegrating Tablets Market Value by Application: (2024-2030)
1.3.2 CNS Diseases
1.3.3 Gastrointestinal Diseases
1.3.4 CVS Diseases
1.3.5 Other
1.4 Global Orally Disintegrating Tablets Market Size Estimates and Forecasts
1.4.1 Global Orally Disintegrating Tablets Revenue 2019-2030
1.4.2 Global Orally Disintegrating Tablets Sales 2019-2030
1.4.3 Global Orally Disintegrating Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Orally Disintegrating Tablets Market Competition by Manufacturers
2.1 Global Orally Disintegrating Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Orally Disintegrating Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Orally Disintegrating Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Orally Disintegrating Tablets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Orally Disintegrating Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Orally Disintegrating Tablets, Product Type & Application
2.7 Orally Disintegrating Tablets Market Competitive Situation and Trends
2.7.1 Orally Disintegrating Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Orally Disintegrating Tablets Players Market Share by Revenue
2.7.3 Global Orally Disintegrating Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Orally Disintegrating Tablets Retrospective Market Scenario by Region
3.1 Global Orally Disintegrating Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Orally Disintegrating Tablets Global Orally Disintegrating Tablets Sales by Region: 2019-2030
3.2.1 Global Orally Disintegrating Tablets Sales by Region: 2019-2024
3.2.2 Global Orally Disintegrating Tablets Sales by Region: 2025-2030
3.3 Global Orally Disintegrating Tablets Global Orally Disintegrating Tablets Revenue by Region: 2019-2030
3.3.1 Global Orally Disintegrating Tablets Revenue by Region: 2019-2024
3.3.2 Global Orally Disintegrating Tablets Revenue by Region: 2025-2030
3.4 North America Orally Disintegrating Tablets Market Facts & Figures by Country
3.4.1 North America Orally Disintegrating Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Orally Disintegrating Tablets Sales by Country (2019-2030)
3.4.3 North America Orally Disintegrating Tablets Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Orally Disintegrating Tablets Market Facts & Figures by Country
3.5.1 Europe Orally Disintegrating Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Orally Disintegrating Tablets Sales by Country (2019-2030)
3.5.3 Europe Orally Disintegrating Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Orally Disintegrating Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Orally Disintegrating Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Orally Disintegrating Tablets Sales by Country (2019-2030)
3.6.3 Asia Pacific Orally Disintegrating Tablets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Orally Disintegrating Tablets Market Facts & Figures by Country
3.7.1 Latin America Orally Disintegrating Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Orally Disintegrating Tablets Sales by Country (2019-2030)
3.7.3 Latin America Orally Disintegrating Tablets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Orally Disintegrating Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Orally Disintegrating Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Orally Disintegrating Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Orally Disintegrating Tablets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Orally Disintegrating Tablets Sales by Type (2019-2030)
4.1.1 Global Orally Disintegrating Tablets Sales by Type (2019-2024)
4.1.2 Global Orally Disintegrating Tablets Sales by Type (2025-2030)
4.1.3 Global Orally Disintegrating Tablets Sales Market Share by Type (2019-2030)
4.2 Global Orally Disintegrating Tablets Revenue by Type (2019-2030)
4.2.1 Global Orally Disintegrating Tablets Revenue by Type (2019-2024)
4.2.2 Global Orally Disintegrating Tablets Revenue by Type (2025-2030)
4.2.3 Global Orally Disintegrating Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Orally Disintegrating Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Orally Disintegrating Tablets Sales by Application (2019-2030)
5.1.1 Global Orally Disintegrating Tablets Sales by Application (2019-2024)
5.1.2 Global Orally Disintegrating Tablets Sales by Application (2025-2030)
5.1.3 Global Orally Disintegrating Tablets Sales Market Share by Application (2019-2030)
5.2 Global Orally Disintegrating Tablets Revenue by Application (2019-2030)
5.2.1 Global Orally Disintegrating Tablets Revenue by Application (2019-2024)
5.2.2 Global Orally Disintegrating Tablets Revenue by Application (2025-2030)
5.2.3 Global Orally Disintegrating Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Orally Disintegrating Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva Orally Disintegrating Tablets Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Orally Disintegrating Tablets Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Orally Disintegrating Tablets Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Orally Disintegrating Tablets Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Johnson and Johnson
6.5.1 Johnson and Johnson Corporation Information
6.5.2 Johnson and Johnson Description and Business Overview
6.5.3 Johnson and Johnson Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson and Johnson Orally Disintegrating Tablets Product Portfolio
6.5.5 Johnson and Johnson Recent Developments/Updates
6.6 GSK
6.6.1 GSK Corporation Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GSK Orally Disintegrating Tablets Product Portfolio
6.6.5 GSK Recent Developments/Updates
6.7 Otsuka
6.6.1 Otsuka Corporation Information
6.6.2 Otsuka Description and Business Overview
6.6.3 Otsuka Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Otsuka Orally Disintegrating Tablets Product Portfolio
6.7.5 Otsuka Recent Developments/Updates
6.8 Eli Lilly and Company
6.8.1 Eli Lilly and Company Corporation Information
6.8.2 Eli Lilly and Company Description and Business Overview
6.8.3 Eli Lilly and Company Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Eli Lilly and Company Orally Disintegrating Tablets Product Portfolio
6.8.5 Eli Lilly and Company Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Corporation Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AstraZeneca Orally Disintegrating Tablets Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Corporation Information
6.10.2 Bristol-Myers Squibb Description and Business Overview
6.10.3 Bristol-Myers Squibb Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bristol-Myers Squibb Orally Disintegrating Tablets Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments/Updates
6.11 Conquer
6.11.1 Conquer Corporation Information
6.11.2 Conquer Orally Disintegrating Tablets Description and Business Overview
6.11.3 Conquer Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Conquer Orally Disintegrating Tablets Product Portfolio
6.11.5 Conquer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Orally Disintegrating Tablets Industry Chain Analysis
7.2 Orally Disintegrating Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Orally Disintegrating Tablets Production Mode & Process
7.4 Orally Disintegrating Tablets Sales and Marketing
7.4.1 Orally Disintegrating Tablets Sales Channels
7.4.2 Orally Disintegrating Tablets Distributors
7.5 Orally Disintegrating Tablets Customers
8 Orally Disintegrating Tablets Market Dynamics
8.1 Orally Disintegrating Tablets Industry Trends
8.2 Orally Disintegrating Tablets Market Drivers
8.3 Orally Disintegrating Tablets Market Challenges
8.4 Orally Disintegrating Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Orally Disintegrating Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Orally Disintegrating Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Orally Disintegrating Tablets Market Competitive Situation by Manufacturers in 2023
Table 4. Global Orally Disintegrating Tablets Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Orally Disintegrating Tablets Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Orally Disintegrating Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Orally Disintegrating Tablets Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Orally Disintegrating Tablets Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Orally Disintegrating Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Orally Disintegrating Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Orally Disintegrating Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Orally Disintegrating Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Orally Disintegrating Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Tablets as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Orally Disintegrating Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Orally Disintegrating Tablets Sales by Region (2019-2024) & (K Units)
Table 18. Global Orally Disintegrating Tablets Sales Market Share by Region (2019-2024)
Table 19. Global Orally Disintegrating Tablets Sales by Region (2025-2030) & (K Units)
Table 20. Global Orally Disintegrating Tablets Sales Market Share by Region (2025-2030)
Table 21. Global Orally Disintegrating Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Orally Disintegrating Tablets Revenue Market Share by Region (2019-2024)
Table 23. Global Orally Disintegrating Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Orally Disintegrating Tablets Revenue Market Share by Region (2025-2030)
Table 25. North America Orally Disintegrating Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Orally Disintegrating Tablets Sales by Country (2019-2024) & (K Units)
Table 27. North America Orally Disintegrating Tablets Sales by Country (2025-2030) & (K Units)
Table 28. North America Orally Disintegrating Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Orally Disintegrating Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Orally Disintegrating Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Orally Disintegrating Tablets Sales by Country (2019-2024) & (K Units)
Table 32. Europe Orally Disintegrating Tablets Sales by Country (2025-2030) & (K Units)
Table 33. Europe Orally Disintegrating Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Orally Disintegrating Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Orally Disintegrating Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Orally Disintegrating Tablets Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Orally Disintegrating Tablets Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Orally Disintegrating Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Orally Disintegrating Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Orally Disintegrating Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Orally Disintegrating Tablets Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Orally Disintegrating Tablets Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Orally Disintegrating Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Orally Disintegrating Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Orally Disintegrating Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Orally Disintegrating Tablets Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Orally Disintegrating Tablets Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Orally Disintegrating Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Orally Disintegrating Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Orally Disintegrating Tablets Sales (K Units) by Type (2019-2024)
Table 51. Global Orally Disintegrating Tablets Sales (K Units) by Type (2025-2030)
Table 52. Global Orally Disintegrating Tablets Sales Market Share by Type (2019-2024)
Table 53. Global Orally Disintegrating Tablets Sales Market Share by Type (2025-2030)
Table 54. Global Orally Disintegrating Tablets Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Orally Disintegrating Tablets Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Orally Disintegrating Tablets Revenue Market Share by Type (2019-2024)
Table 57. Global Orally Disintegrating Tablets Revenue Market Share by Type (2025-2030)
Table 58. Global Orally Disintegrating Tablets Price (USD/Unit) by Type (2019-2024)
Table 59. Global Orally Disintegrating Tablets Price (USD/Unit) by Type (2025-2030)
Table 60. Global Orally Disintegrating Tablets Sales (K Units) by Application (2019-2024)
Table 61. Global Orally Disintegrating Tablets Sales (K Units) by Application (2025-2030)
Table 62. Global Orally Disintegrating Tablets Sales Market Share by Application (2019-2024)
Table 63. Global Orally Disintegrating Tablets Sales Market Share by Application (2025-2030)
Table 64. Global Orally Disintegrating Tablets Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Orally Disintegrating Tablets Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Orally Disintegrating Tablets Revenue Market Share by Application (2019-2024)
Table 67. Global Orally Disintegrating Tablets Revenue Market Share by Application (2025-2030)
Table 68. Global Orally Disintegrating Tablets Price (USD/Unit) by Application (2019-2024)
Table 69. Global Orally Disintegrating Tablets Price (USD/Unit) by Application (2025-2030)
Table 70. Teva Corporation Information
Table 71. Teva Description and Business Overview
Table 72. Teva Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Teva Orally Disintegrating Tablets Product
Table 74. Teva Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Merck Orally Disintegrating Tablets Product
Table 79. Merck Recent Developments/Updates
Table 80. Mylan Corporation Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Mylan Orally Disintegrating Tablets Product
Table 84. Mylan Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Pfizer Orally Disintegrating Tablets Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Johnson and Johnson Corporation Information
Table 91. Johnson and Johnson Description and Business Overview
Table 92. Johnson and Johnson Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Johnson and Johnson Orally Disintegrating Tablets Product
Table 94. Johnson and Johnson Recent Developments/Updates
Table 95. GSK Corporation Information
Table 96. GSK Description and Business Overview
Table 97. GSK Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. GSK Orally Disintegrating Tablets Product
Table 99. GSK Recent Developments/Updates
Table 100. Otsuka Corporation Information
Table 101. Otsuka Description and Business Overview
Table 102. Otsuka Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Otsuka Orally Disintegrating Tablets Product
Table 104. Otsuka Recent Developments/Updates
Table 105. Eli Lilly and Company Corporation Information
Table 106. Eli Lilly and Company Description and Business Overview
Table 107. Eli Lilly and Company Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Eli Lilly and Company Orally Disintegrating Tablets Product
Table 109. Eli Lilly and Company Recent Developments/Updates
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. AstraZeneca Orally Disintegrating Tablets Product
Table 114. AstraZeneca Recent Developments/Updates
Table 115. Bristol-Myers Squibb Corporation Information
Table 116. Bristol-Myers Squibb Description and Business Overview
Table 117. Bristol-Myers Squibb Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Bristol-Myers Squibb Orally Disintegrating Tablets Product
Table 119. Bristol-Myers Squibb Recent Developments/Updates
Table 120. Conquer Corporation Information
Table 121. Conquer Description and Business Overview
Table 122. Conquer Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Conquer Orally Disintegrating Tablets Product
Table 124. Conquer Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Orally Disintegrating Tablets Distributors List
Table 128. Orally Disintegrating Tablets Customers List
Table 129. Orally Disintegrating Tablets Market Trends
Table 130. Orally Disintegrating Tablets Market Drivers
Table 131. Orally Disintegrating Tablets Market Challenges
Table 132. Orally Disintegrating Tablets Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Orally Disintegrating Tablets
Figure 2. Global Orally Disintegrating Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Orally Disintegrating Tablets Market Share by Type in 2023 & 2030
Figure 4. Anti-Psychotics Drug Product Picture
Figure 5. Anti-Epileptics Drug Product Picture
Figure 6. Other Product Picture
Figure 7. Global Orally Disintegrating Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Orally Disintegrating Tablets Market Share by Application in 2023 & 2030
Figure 9. CNS Diseases
Figure 10. Gastrointestinal Diseases
Figure 11. CVS Diseases
Figure 12. Other
Figure 13. Global Orally Disintegrating Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Orally Disintegrating Tablets Market Size (2019-2030) & (US$ Million)
Figure 15. Global Orally Disintegrating Tablets Sales (2019-2030) & (K Units)
Figure 16. Global Orally Disintegrating Tablets Average Price (USD/Unit) & (2019-2030)
Figure 17. Orally Disintegrating Tablets Report Years Considered
Figure 18. Orally Disintegrating Tablets Sales Share by Manufacturers in 2023
Figure 19. Global Orally Disintegrating Tablets Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Orally Disintegrating Tablets Players: Market Share by Revenue in 2023
Figure 21. Orally Disintegrating Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Orally Disintegrating Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Orally Disintegrating Tablets Sales Market Share by Country (2019-2030)
Figure 24. North America Orally Disintegrating Tablets Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Orally Disintegrating Tablets Sales Market Share by Country (2019-2030)
Figure 28. Europe Orally Disintegrating Tablets Revenue Market Share by Country (2019-2030)
Figure 29. Germany Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Orally Disintegrating Tablets Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Orally Disintegrating Tablets Revenue Market Share by Region (2019-2030)
Figure 36. China Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Orally Disintegrating Tablets Sales Market Share by Country (2019-2030)
Figure 47. Latin America Orally Disintegrating Tablets Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Orally Disintegrating Tablets Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Orally Disintegrating Tablets Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Orally Disintegrating Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Orally Disintegrating Tablets by Type (2019-2030)
Figure 57. Global Revenue Market Share of Orally Disintegrating Tablets by Type (2019-2030)
Figure 58. Global Orally Disintegrating Tablets Price (USD/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Orally Disintegrating Tablets by Application (2019-2030)
Figure 60. Global Revenue Market Share of Orally Disintegrating Tablets by Application (2019-2030)
Figure 61. Global Orally Disintegrating Tablets Price (USD/Unit) by Application (2019-2030)
Figure 62. Orally Disintegrating Tablets Value Chain
Figure 63. Orally Disintegrating Tablets Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
